Tessera Diagnostics targets accurate prostrate cancer test
This article was originally published in Clinica
Executive Summary
Tessera Diagnostics is sponsoring a research programme to develop highly specific immunoassays for the early diagnosis of prostate cancer, which are claimed may replace the conventional diagnostic technique.